Supplemental Material - Comparison of comorbidities and adverse events in dermatology and rheumatology patients prescribed tofacitinib: a retrospective analysis

Published: 21 November 2023| Version 2 | DOI: 10.17632/wbvrdw2x2x.2
Contributors:
,
,
,
,
,
,
,
,
,
,

Description

Supplemental methods and results for the publication entitled, “Comparison of comorbidities and adverse events in dermatology and rheumatology patients prescribed tofacitinib: a retrospective analysis.”

Files

Institutions

NYU Langone Health

Categories

Dermatology, Infectious Disease, Rheumatology, Adverse Effect of Drug, Drug Safety, Janus Kinase

Licence